Evidence map›Paper›PMID 27917940›Full record

ArticleScientific reports2016

Ubiquitin Ligase NEDD4 Regulates PPARγ Stability and Adipocyte Differentiation in 3T3-L1 Cells.

Jing Jing Li, Ruishan Wang, Rati Lama, Xinjiang Wang, Z Elizabeth Floyd, Edwards A Park, Francesca-Fang Liao

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Regulation of PPARγ2 Stability and Activity by SHP-1.Molecular and cellular biology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jing Jing LiDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA.
Ruishan WangDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA.
Rati LamaDepartment of Pharmacology &Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Xinjiang WangDepartment of Pharmacology &Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Z Elizabeth FloydUbiquitin Biology Laboratory, Pennington Biomedical Research Center, Louisiana State University Systems, Baton Rouge, LA 70808, USA.
Edwards A ParkDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA.
Francesca-Fang LiaoDepartment of Pharmacology, University of Tennessee Health Science Center, Memphis, Tennessee 38103, USA.
University of Tennessee Health Science Center · USRoswell Park Comprehensive Cancer Center · USMemphis VA Medical Center · USPennington Biomedical Research Center · US

Funding

Is HSF1 the key in mediating Hsp90 inhibitor effect in AD?R01AG049772 · NIA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LIAO, FRANCESCA-FANG · 2015 to 2019
$1.4M
Regulation of Insulin Sensitivity by the Ubiquitin Ligase Siah2R01DK099625 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI FLOYD, ZELPHA ELIZABETH · 2014 to 2017
$1.2M
Nuclear receptor signaling in BACE1 gene repression under neuroinflammationR21NS083908 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LIAO, FRANCESCA-FANG, PARK, EDWARDS A · 2013 to 2014
$411k
Secretory phospholipase A2 enhances metabolic rateI01BX002408 · VA · MEMPHIS VA MEDICAL CENTER · PI PARK, EDWARDS A · 2015 to 2024
–
BLRD VA I01 BX002408NIA NIH HHS R01 AG049772NIDDK NIH HHS R01 DK099625NINDS NIH HHS R21 NS083908
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor-γ (PPARγ) is a ligand-activated nuclear receptor which controls lipid and glucose metabolism. It is also the master regulator of adipogenesis. In adipocytes, ligand-dependent PPARγ activation is associated with proteasomal degradation; therefore, regulation of PPARγ degradation may modulate its transcriptional activity. Here, we show that neural precursor cell expressed developmentally down-regulated protein 4 (NEDD4), an E3 ubiquitin ligase, interacts with the hinge and ligand binding domains of PPARγ and is a bona fide E3 ligase for PPARγ. NEDD4 increases PPARγ stability through the inhibition of its proteasomal degradation. Knockdown of NEDD4 in 3T3-L1 adipocytes reduces PPARγ protein levels and suppresses adipocyte conversion. PPARγ correlates positively with NEDD4 in obese adipose tissue. Together, these findings support NEDD4 as a novel regulator of adipogenesis by modulating the stability of PPARγ.

Indexed as

Cell Differentiation3T3-L1 CellsAdipocytesAdipogenesisAdipose TissueAnimalsCHO CellsCricetinaeCricetulusGene Knockdown TechniquesHEK293 CellsHumansLigandsLysineMiceNedd4 Ubiquitin Protein LigasesLigandsLysineNedd4 protein, mouseNedd4 Ubiquitin Protein LigasesPPAR gamma

Identifiers

PMID27917940
PMCPMC5137149
OpenAlexW2560290645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.